Inhibrx Capital Stock from 2010 to 2025

INBX Stock

USD 14.72 0.37 2.58%

Inhibrx Capital Stock yearly trend continues to be fairly stable with very little volatility. Capital Stock will likely drop to 950.00 in 2025. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

1000

Current Value

950

Quarterly Volatility

1 K

Credit Downgrade

Yuan Drop

Covid

Check Inhibrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibrx's main balance sheet or income statement drivers, such as Interest Expense of 10.6 M, Minority Interest of 0.0 or Tax Provision of 1.9 K, as well as many indicators such as Price To Sales Ratio of 1.2 K, Dividend Yield of 0.0021 or PTB Ratio of 1.79. Inhibrx financial statements analysis is a perfect complement when working with Inhibrx Valuation or Volatility modules.

Check out the analysis of Inhibrx Correlation against competitors.

For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.

Latest Inhibrx's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Inhibrx over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Inhibrx's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inhibrx's overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Capital Stock

Timeline

Inhibrx Capital Stock Regression Statistics

	Arithmetic Mean	2,997
	Geometric Mean	2,769
	Coefficient Of Variation	34.68
	Mean Deviation	630.08
	Median	3,000
	Standard Deviation	1,039
	Sample Variance	1.1M
	Range	4K
	R-Value	(0.11)
	Mean Square Error	1.1M
	R-Squared	0.01
	Significance	0.68
	Slope	(24.63)
	Total Sum of Squares	16.2M

Inhibrx Capital Stock History

	2025	950.0
	2024	1000.0
	2023	5000.0
	2020	4000.0
	2019	2000.0

Other Fundumenentals of Inhibrx

Issuance Of Capital Stock

Inhibrx Capital Stock component correlations

	Net Tangible Assets	Retained Earnings	Accounts Payable	Total Current Assets	Property Plant Equipment	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Deferred Long Term Liab	Capital Stock	Common Stock	Long Term Debt Total	Capital Surpluse
Net Tangible Assets		-0.57	0.68	0.77	0.12	0.78	0.93	-0.73	-0.89	0.71	-0.16	0.3	0.81	-0.62	0.78	-0.82	-0.45	0.15	0.15	0.7	0.67
Retained Earnings	-0.57		-0.61	-0.93	-0.22	-0.92	-0.45	0.43	0.48	-0.66	0.11	-0.93	-0.89	0.65	-0.91	0.49	0.0	-0.56	-0.56	-0.64	-0.7
Accounts Payable	0.68	-0.61		0.73	0.63	0.76	0.72	-0.37	-0.78	0.61	-0.3	0.48	0.7	-0.75	0.72	-0.84	-0.3	0.16	0.16	0.57	0.58
Total Current Assets	0.77	-0.93	0.73		0.2	1.0	0.71	-0.59	-0.72	0.83	-0.35	0.82	0.99	-0.77	1.0	-0.72	-0.22	0.36	0.36	0.81	0.85
Property Plant Equipment	0.12	-0.22	0.63	0.2		0.23	0.16	0.45	-0.22	0.03	-0.1	0.21	0.11	-0.63	0.19	-0.55	0.05	0.11	0.11	-0.05	-0.03
Total Assets	0.78	-0.92	0.76	1.0	0.23		0.74	-0.59	-0.76	0.85	-0.37	0.8	0.98	-0.79	0.99	-0.75	-0.27	0.31	0.31	0.83	0.86
Total Stockholder Equity	0.93	-0.45	0.72	0.71	0.16	0.74		-0.69	-0.99	0.83	-0.35	0.2	0.74	-0.68	0.71	-0.85	-0.71	-0.18	-0.18	0.82	0.74
Current Deferred Revenue	-0.73	0.43	-0.37	-0.59	0.45	-0.59	-0.69		0.65	-0.64	0.06	-0.23	-0.65	0.12	-0.61	0.37	0.42	-0.1	-0.1	-0.68	-0.65
Net Debt	-0.89	0.48	-0.78	-0.72	-0.22	-0.76	-0.99	0.65		-0.86	0.41	-0.24	-0.74	0.73	-0.72	0.86	0.72	0.21	0.21	-0.84	-0.78
Long Term Debt	0.71	-0.66	0.61	0.83	0.03	0.85	0.83	-0.64	-0.86		-0.55	0.53	0.82	-0.72	0.82	-0.67	-0.69	-0.2	-0.2	1.0	0.94
Net Receivables	-0.16	0.11	-0.3	-0.35	-0.1	-0.37	-0.35	0.06	0.41	-0.55		-0.25	-0.38	0.47	-0.36	0.43	0.42	0.46	0.46	-0.55	-0.52
Total Liab	0.3	-0.93	0.48	0.82	0.21	0.8	0.2	-0.23	-0.24	0.53	-0.25		0.77	-0.56	0.81	-0.33	0.17	0.57	0.57	0.51	0.6
Net Invested Capital	0.81	-0.89	0.7	0.99	0.11	0.98	0.74	-0.65	-0.74	0.82	-0.38	0.77		-0.72	0.99	-0.71	-0.24	0.34	0.34	0.81	0.86
Short Long Term Debt	-0.62	0.65	-0.75	-0.77	-0.63	-0.79	-0.68	0.12	0.73	-0.72	0.47	-0.56	-0.72		-0.75	0.86	0.34	0.0	0.0	-0.67	-0.7
Net Working Capital	0.78	-0.91	0.72	1.0	0.19	0.99	0.71	-0.61	-0.72	0.82	-0.36	0.81	0.99	-0.75		-0.73	-0.23	0.36	0.36	0.81	0.84
Short Term Debt	-0.82	0.49	-0.84	-0.72	-0.55	-0.75	-0.85	0.37	0.86	-0.67	0.43	-0.33	-0.71	0.86	-0.73		0.41	0.01	0.01	-0.63	-0.64
Deferred Long Term Liab	-0.45	0.0	-0.3	-0.22	0.05	-0.27	-0.71	0.42	0.72	-0.69	0.42	0.17	-0.24	0.34	-0.23	0.41		0.72	0.72	-0.69	-0.46
Capital Stock	0.15	-0.56	0.16	0.36	0.11	0.31	-0.18	-0.1	0.21	-0.2	0.46	0.57	0.34	0.0	0.36	0.01	0.72		1.0	-0.21	-0.07
Common Stock	0.15	-0.56	0.16	0.36	0.11	0.31	-0.18	-0.1	0.21	-0.2	0.46	0.57	0.34	0.0	0.36	0.01	0.72	1.0		-0.21	-0.07
Long Term Debt Total	0.7	-0.64	0.57	0.81	-0.05	0.83	0.82	-0.68	-0.84	1.0	-0.55	0.51	0.81	-0.67	0.81	-0.63	-0.69	-0.21	-0.21		0.94
Capital Surpluse	0.67	-0.7	0.58	0.85	-0.03	0.86	0.74	-0.65	-0.78	0.94	-0.52	0.6	0.86	-0.7	0.84	-0.64	-0.46	-0.07	-0.07	0.94

Click cells to compare fundamentals

About Inhibrx Financial Statements

Inhibrx investors use historical fundamental indicators, such as Inhibrx's Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Inhibrx. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Capital Stock	1,000.00	950.00

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Inhibrx Capital Stock from 2010 to 2025

Latest Inhibrx's Capital Stock Growth Pattern

Inhibrx Capital Stock Regression Statistics

Inhibrx Capital Stock History

Other Fundumenentals of Inhibrx

Inhibrx Capital Stock component correlations

About Inhibrx Financial Statements

Also Currently Popular

Additional Tools for Inhibrx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY